Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201301106 Principal Investigator: Ma, Cynthia
Title: Phase II Trial of Neoadjuvant PD 0332991, a Cyclin-Dependent Kinase (Cdk) 4/6 inhibitor, in Combination with Anastrozole in Women with Clinical Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
Phase: II Disease Site: Breast, Female
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to find out what efects, good and/or bad, the drug PD 0332991 in combination with anastrozole (with or without goserelin) has on the patinet and their breast cancer.
 
More Information:
Clinicaltrials.gov link
Internal Protocol Documents (requires Siteman administrative database password)